AIMS: Endoplasmic reticulum stress followed by the unfolded protein response is one of the cellular mechanisms contributing to the progression of α-synuclein pathology in Parkinson's disease and other Lewy body diseases. We aimed to investigate the activation of endoplasmic reticulum stress and its correlation with α-synuclein pathology in human post-mortem brain tissue. METHODS: We analysed brain tissue from 45 subjects-14 symptomatic patients with Lewy body disease, 19 subjects with incidental Lewy body disease, and 12 healthy controls. The analysed brain regions included the medulla, pons, midbrain, striatum, amygdala and entorhinal, temporal, frontal and occipital cortex. We analysed activation of endoplasmic reticulum stress via levels of the unfolded protein response-related proteins (Grp78, eIF2α) and endoplasmic reticulum stress-regulating neurotrophic factors (MANF, CDNF). RESULTS: We showed that regional levels of two endoplasmic reticulum-localised neurotrophic factors, MANF and CDNF, did not change in response to accumulating α-synuclein pathology. The concentration of MANF negatively correlated with age in specific regions. eIF2α was upregulated in the striatum of Lewy body disease patients and correlated with increased α-synuclein levels. We found the upregulation of chaperone Grp78 in the amygdala and nigral dopaminergic neurons of Lewy body disease patients. Grp78 levels in the amygdala strongly correlated with soluble α-synuclein levels. CONCLUSIONS: Our data suggest a strong but regionally specific change in Grp78 and eIF2α levels, which positively correlates with soluble α-synuclein levels. Additionally, MANF levels decreased in dopaminergic neurons in the substantia nigra. Our research suggests that endoplasmic reticulum stress activation is not associated with Lewy pathology but rather with soluble α-synuclein concentration and disease progression.

Department of Clinical and Molecular Pathology Palacky University Olomouc and University Hospital Olomouc Olomouc Czech Republic

Department of Neurology Palacky University Olomouc and University Hospital Olomouc Olomouc Czech Republic

Institute of Biotechnology Helsinki Institute of Life Science University of Helsinki Helsinki Finland

Mammalian Genetics Unit MRC Harwell Institute Harwell Science and Innovation Campus Didcot UK

Nuffield Department of Clinical Neuroscience University of Oxford Oxford UK

Zobrazit více v PubMed

Dickson DW, Braak H, Duda JE, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 2009;8(12):1150‐1157. doi:10.1016/S1474‐4422(09)70238‐8 Retraction in: Lancet Neurol. 2010 Jan;9(1):29

Shahmoradian SH, Lewis AJ, Genoud C, et al. Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes. Nat Neurosci. 2019;22(7):1099‐1109. doi:10.1038/s41593‐019‐0423‐2

Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H. The Lewy body in Parkinson's disease and related neurodegenerative disorders. Mol Neurobiol. 2013;47(2):495‐508. doi:10.1007/s12035‐012‐8280‐y

Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197‐211. doi:10.1016/s0197‐4580(02)00065‐9

Parkkinen L, Pirttilä T, Alafuzoff I. Applicability of current staging/categorization of alpha‐synuclein pathology and their clinical relevance. Acta Neuropathol. 2008;115(4):399‐407. doi:10.1007/s00401‐008‐0346‐6

Parkkinen L, O'Sullivan SS, Collins C, et al. Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease. J Parkinsons Dis. 2011;1(3):277‐286. doi:10.3233/JPD‐2011‐11046

Mercado G, Valdés P, Hetz C. An ERcentric view of Parkinson's disease. Trends Mol Med. 2013;19(3):165‐175. doi:10.1016/j.molmed.2012.12.005

Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334(6059):1081‐1086. doi:10.1126/science.1209038

Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13(2):89‐102. Published 2012 Jan 18. doi:10.1038/nrm3270

Acosta‐Alvear D, Zhou Y, Blais A, et al. XBP1 controls diverse cell type‐ and condition‐specific transcriptional regulatory networks. Mol Cell. 2007;27(1):53‐66. doi:10.1016/j.molcel.2007.06.011

Hetz C, Saxena S. ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017;13(8):477‐491. doi:10.1038/nrneurol.2017.99

Urra H, Dufey E, Lisbona F, Rojas‐Rivera D, Hetz C. When ER stress reaches a dead end. Biochim Biophys Acta. 2013;1833(12):3507‐3517. doi:10.1016/j.bbamcr.2013.07.024

Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha‐mediated NF‐kappaB activation and down‐regulation of TRAF2 expression. Mol Cell Biol. 2006;26(8):3071‐3084. doi:10.1128/MCB.26.8.3071‐3084.2006

Lindholm P, Saarma M. Novel CDNF/MANF family of neurotrophic factors. Dev Neurobiol. 2010;70(5):360‐371. doi:10.1002/dneu.20760

Lindholm P, Voutilainen MH, Laurén J, et al. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature. 2007;448(7149):73‐77. doi:10.1038/nature05957

Voutilainen MH, Bäck S, Peränen J, et al. Chronic infusion of CDNF prevents 6‐OHDA‐induced deficits in a rat model of Parkinson's disease. Exp Neurol. 2011;228(1):99‐108. doi:10.1016/j.expneurol.2010.12.013

Arancibia D, Zamorano P, Andrés ME. CDNF induces the adaptive unfolded protein response and attenuates endoplasmic reticulum stress‐induced cell death. Biochim Biophys Acta Mol Cell Res. 2018;1865(11 Pt A):1579‐1589. doi:10.1016/j.bbamcr.2018.08.012

Latge C, Cabral KM, de Oliveira GA, et al. The solution structure and dynamics of full‐length human cerebral dopamine neurotrophic factor and its neuroprotective role against α‐Synuclein oligomers. J Biol Chem. 2015;290(33):20527‐20540. doi:10.1074/jbc.M115.662254

Albert K, Raymundo DP, Panhelainen A, et al. Cerebral dopamine neurotrophic factor reduces α‐synuclein aggregation and propagation and alleviates behavioral alterations in vivo. Mol Ther. 2021;29(9):2821‐2840. doi:10.1016/j.ymthe.2021.04.035

Mizobuchi N, Hoseki J, Kubota H, et al. ARMET is a soluble ER protein induced by the unfolded protein response via ERSE‐II element. Cell Struct Funct. 2007;32(1):41‐50. doi:10.1247/csf.07001

Tadimalla A, Belmont PJ, Thuerauf DJ, et al. Mesencephalic astrocyte‐derived neurotrophic factor is an ischemia‐inducible secreted endoplasmic reticulum stress response protein in the heart. Circ Res. 2008;103(11):1249‐1258. doi:10.1161/CIRCRESAHA.108.180679

Lindholm P, Peränen J, Andressoo JO, et al. MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain. Mol Cell Neurosci. 2008;39(3):356‐371. doi:10.1016/j.mcn.2008.07.016

Henderson MJ, Richie CT, Airavaara M, Wang Y, Harvey BK. Mesencephalic astrocyte‐derived neurotrophic factor (MANF) secretion and cell surface binding are modulated by KDEL receptors. J Biol Chem. 2013;288(6):4209‐4225. doi:10.1074/jbc.M112.400648

Eesmaa A, Yu LY, Göös H, et al. The cytoprotective protein MANF promotes neuronal survival independently from its role as a GRP78 cofactor. J Biol Chem. 2021;296:100295. doi:10.1016/j.jbc.2021.100295

Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci. 2002;22(24):10690‐10698. doi:10.1523/JNEUROSCI.22‐24‐10690.2002

Smith WW, Jiang H, Pei Z, et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha‐synuclein‐induced toxicity. Hum Mol Genet. 2005;14(24):3801‐3811. doi:10.1093/hmg/ddi396

Mercado G, Castillo V, Soto P, Sidhu A. ER stress and Parkinson's disease: pathological inputs that converge into the secretory pathway. Brain Res. 2016;1648(Pt B):626‐632. doi:10.1016/j.brainres.2016.04.042

Heman‐Ackah SM, Manzano R, Hoozemans JJM, et al. Alpha‐synuclein induces the unfolded protein response in Parkinson's disease SNCA triplication iPSC‐derived neurons. Hum Mol Genet. 2017;26(22):4441‐4450. doi:10.1093/hmg/ddx331

Bellucci A, Navarria L, Zaltieri M, et al. Induction of the unfolded protein response by α‐synuclein in experimental models of Parkinson's disease. J Neurochem. 2011;116(4):588‐605. doi:10.1111/j.1471‐4159.2010.07143.x

Colla E, Coune P, Liu Y, et al. Endoplasmic reticulum stress is important for the manifestations of α‐synucleinopathy in vivo. J Neurosci. 2012;32(10):3306‐3320. doi:10.1523/JNEUROSCI.5367‐11.2012

Cooper AA, Gitler AD, Cashikar A, et al. Alpha‐synuclein blocks ER‐Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science. 2006;313(5785):324‐328. doi:10.1126/science.1129462

Sugeno N, Takeda A, Hasegawa T, et al. Serine 129 phosphorylation of alpha‐synuclein induces unfolded protein response‐mediated cell death. J Biol Chem. 2008;283(34):23179‐23188. doi:10.1074/jbc.M802223200

Credle JJ, Forcelli PA, Delannoy M, et al. α‐Synuclein‐mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease. Neurobiol Dis. 2015;76:112‐125. doi:10.1016/j.nbd.2015.02.005

Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W. Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun. 2007;354(3):707‐711. doi:10.1016/j.bbrc.2007.01.043

Galli E, Härkönen T, Sainio MT, et al. Increased circulating concentrations of mesencephalic astrocyte‐derived neurotrophic factor in children with type 1 diabetes. Sci Rep. 2016;6(1):29058. Published 2016 Jun 30. doi:10.1038/srep29058

Galli E, Lindholm P, Kontturi LS, Saarma M, Urtti A, Yliperttula M. Characterization of CDNF‐secreting ARPE‐19 cell clones for encapsulated cell therapy. Cell Transplant. 2019;28(4):413‐424. doi:10.1177/0963689719827943

Diner I, Nguyen T, Seyfried NT. Enrichment of detergent‐insoluble protein aggregates from human postmortem brain. J vis Exp. 2017;(128):55835. Published 2017 Oct 24. doi:10.3791/55835

Schweighauser M, Shi Y, Tarutani A, et al. Structures of α‐synuclein filaments from multiple system atrophy. Nature. 2020;585(7825):464‐469. doi:10.1038/s41586‐020‐2317‐6

Desjardins P, Conklin D. NanoDrop microvolume quantitation of nucleic acids. J vis Exp. 2010;(45):2565. Published 2010 Nov 22. doi:10.3791/2565

Sarcinelli C, Dragic H, Piecyk M, et al. ATF4‐dependent NRF2 transcriptional regulation promotes antioxidant protection during endoplasmic reticulum stress. Cancers (Basel). 2020;12. Published 2020 Mar 1(3):569. doi:10.3390/cancers12030569

Sousa‐Victor P, Neves J, Cedron‐Craft W, et al. MANF regulates metabolic and immune homeostasis in ageing and protects against liver damage. Nat Metab. 2019;1(2):276‐290. doi:10.1038/s42255‐018‐0023‐6

Baek JH, Mamula D, Tingstam B, Pereira M, He Y, Svenningsson P. GRP78 level is altered in the brain, but not in plasma or cerebrospinal fluid in Parkinson's disease patients. Front Neurosci. 2019;13:697. Published 2019 Jul 5. doi:10.3389/fnins.2019.00697

Nemani VM, Lu W, Berge V, et al. Increased expression of alpha‐synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron. 2010;65(1):66‐79. doi:10.1016/j.neuron.2009.12.023

Colla E. Linking the endoplasmic reticulum to Parkinson's disease and alpha‐synucleinopathy. Front Neurosci. 2019;13:560. Published 2019 May 29. doi:10.3389/fnins.2019.00560

Iacono D, Geraci‐Erck M, Rabin ML, et al. Parkinson disease and incidental Lewy body disease: just a question of time? Neurology. 2015;85(19):1670‐1679. doi:10.1212/WNL.0000000000002102

Mercado G, Castillo V, Soto P, et al. Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease. Neurobiol Dis. 2018;112:136‐148. doi:10.1016/j.nbd.2018.01.004

Halliday M, Radford H, Sekine Y, et al. Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity. Cell Death Dis. 2015;6(3):e1672. Published 2015 Mar 5. doi:10.1038/cddis.2015.49

Halliday M, Radford H, Zents KAM, et al. Repurposed drugs targeting eIF2α‐P‐mediated translational repression prevent neurodegeneration in mice. Brain. 2017;140(6):1768‐1783. doi:10.1093/brain/awx074

Herantis Pharma. CDNF phase I 12‐month topline results: safety, UPDRS and DAT PET data. 2020. https://herantis.com/wp-content/uploads/2020/09/200915-CDNF-Webinar_FINAL.pdf. Accessed Nov 3, 2020.